Tandem’s t:slim X2 insulin pump connected to the Dexcom G5 CGM was approved by the FDA in August, 2017. The Dexcom G5 is currently the most accurate CGM on the market and will soon be followed by the G6 CGM that will have greater accuracy, no Tylenol interference, and may eventually require no calibrations. Besides the simplicity of its color touchscreen interface, the X2 is the first and only pump that allows remote software updates. This allows users to automatically upgrade the pump software without waiting for their insurance to approve a new pump body 4 to 5 years later.
Tandem Diabetes Care, Inc. is a privately held company dedicated to advancing the management of diabetes through novel technologies. The Company offers a comprehensive, user-centric and integrated approach to product design, development, and customer care. Tandem Diabetes makes the t:slim insulin pump, an innovative touchscreen insulin pump for people with diabetes.
The t:slim G4 Pump, an insulin pump paired with the popular Dexcom continuous glucose monitoring system, has received FDA approval and Tandem is ready to take your orders. The t:slim G4 conveniently combines CGM graphs and trend information with current insulin delivery activity on a single color touch screen, also reducing the number of devices you need to carry.
When a pump company brings out a new pump, wearers using the prior models often want to upgrade to the latest and greatest device for its advancements or improvements in software or hardware. And based on usual industry practice, they expect an upgrade policy that allows them to buy the new pump at a reduced price. Tandem Pump Company recently announced the good news that FDA approval for the new t:slim G4 insulin pump that comes with a built-in Dexcom G4 is expected later this year. This new pump has a new body, new software, and new parts that allow it to display Dexcom G4 data right on the pump screen. Tandem will be ready to ship 30 days after approval.
At the 72nd Scientific Sessions of the American Diabetes Association, Tandem announced that it will begin accepting orders for the t:slim™ Insulin Delivery System, the first insulin pump approved by the FDA with a touch screen, on Monday, June 11, 2012 starting at 6:00am. The product will begin shipping in August 2012.
Full press release is below.
A quick contact list of the big companies in diabetes, including phones numbers and links to their sites.
Although patch pumps applied directly to the skin are more available, most pumps infuse insulin from a pump reservoir through an infusion set. No single set works well for everyone, so choosing an infusion set can be difficult. The type of set shipped with a new pump is usually one manufactured by the pump company and this set may or may not be the best choice. Fortunately, there are many alternatives to choose from.